Trial comparisons

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=41

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT04614948-009cba48",
        "title": "Double Blind Phase: Ad26.COV2.S vs Double Blind Phase: Placebo: Double Blind Phase: Number of Participants With First Occurrence of Molecularly Confirmed COVID-19 Defined by the US FDA Harmonized Case Definition With Onset at Least 14 Days After the Second Vaccination",
        "summary": "12 of 6024 against 52 of 5615; risk difference -0.7 points, 95% interval -1.0 to -0.5; NCT04614948, A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults",
        "record": "/library/comparisons/NCT04614948-009cba48",
        "nct_id": "NCT04614948",
        "kind": "outcome",
        "participants": 11639,
        "risk_difference": {
          "value": -0.007268876408879176,
          "lower": -0.010255451559089126,
          "upper": -0.004620653636096584
        },
        "group_1": "12 of 6,024",
        "group_2": "52 of 5,615",
        "difference": "-0.7 points",
        "interval": "-1.0 to -0.5",
        "trial_title": "A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults"
      },
      {
        "id": "NCT04614948-221d2d82",
        "title": "Double Blind Phase: Ad26.COV2.S vs Double Blind Phase: Placebo: Double Blind Phase: Number of Participants With First Occurrence of SARS-CoV-2 Infection (Serologically and/or Molecularly Confirmed) With Onset at Least 14 Days After the Second Vaccination",
        "summary": "60 of 6024 against 113 of 5615; risk difference -1.0 points, 95% interval -1.5 to -0.6; NCT04614948, A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults",
        "record": "/library/comparisons/NCT04614948-221d2d82",
        "nct_id": "NCT04614948",
        "kind": "outcome",
        "participants": 11639,
        "risk_difference": {
          "value": -0.010164506710468901,
          "lower": -0.01474898113409532,
          "upper": -0.005767301855385971
        },
        "group_1": "60 of 6,024",
        "group_2": "113 of 5,615",
        "difference": "-1.0 points",
        "interval": "-1.5 to -0.6",
        "trial_title": "A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "None stated"
    }
  ],
  "next": "/api/comparisons/v1?page=42",
  "request_id": "RQmDKYW0XVv0fd8J"
}